Abstract：
Immune checkpoint inhibitors have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events, including pituitary complications. Autoimmune hypophysitis, traditionally a rare diagnosis, has become a more frequently encountered clinical entity with the emergence of antitumor immunotherapy. This mini-review aims to consolidate current knowledge, encompassing the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of pituitary complications of immune checkpoint inhibitor use.
摘要：
免疫检查点抑制剂（ICIs）彻底改变了癌症治疗，但与内分泌免疫相关不良事件（irAE）的风险有关。包括垂体并发症.自身免疫性垂体炎,传统上是一种罕见的诊断，随着抗肿瘤免疫疗法的出现，已成为更频繁遇到的临床实体。这个小型审查旨在巩固当前的知识，包括流行病学，病理生理学,临床表现,诊断,ICI使用的垂体并发症的处理。
